{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:48:40Z","timestamp":1784249320363,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,7,4]],"date-time":"2008-07-04T00:00:00Z","timestamp":1215129600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2008,7,4]],"date-time":"2008-07-04T00:00:00Z","timestamp":1215129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>To date, a specific marker to evaluate and predict the clinical course or complication of the liver-transplanted patient is not available in clinical practice. Increased procalcitonin (PCT) levels have been found in infectious inflammation; poor organ perfusion and high PCT levels in the cardiac donor appeared to predict early graft failure. We evaluated PCT as a predictor of early graft dysfunction and postoperative complications.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>PCT serum concentrations were measured in samples collected before organ retrieval from 67 consecutive brain-dead donors and in corresponding recipients from day 0, before liver transplantation, up to day 7 after liver transplantation. The following parameters were recorded in donors: amount of vasopressive drug doses, cardiac arrest history 24 hours before retrieval, number of days in the intensive care unit, age of donor, and infection in donor, and the following parameters were recorded in recipients: cold and warm ischemia time, veno-venous bypass, transfusion amount during orthotopic liver transplantation (OLT), and occurrence of postoperative complication or hepatic dysfunction.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>In the donor, the preoperative level of PCT was associated with cardiac arrest and high doses of catecholamines before organ retrieval. In the recipient, elevated PCT levels were observed early after OLT, with a peak at day 1 or 2 after OLT, then a decrease until day 7. A postoperative peak of PCT levels was associated neither with preoperative PCT levels in the donor or the recipients nor with hepatic post-OLT dysfunction or other postoperative complications, but with two donor parameters: infection and cardiac arrest.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>PCT level in the donor and early PCT peak in the recipient are not predictive of post-OLT hepatic dysfunction or other complications. Cardiac arrest and infection in the donor, but not PCT level in the donor, are associated with high post-OLT PCT levels in the recipient.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/cc6942","type":"journal-article","created":{"date-parts":[[2008,7,4]],"date-time":"2008-07-04T18:14:07Z","timestamp":1215195247000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Procalcitonin in liver transplantation: are high levels due to donors or recipients?"],"prefix":"10.1186","volume":"12","author":[{"given":"Daniel","family":"Eyraud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa\u00efd","family":"Ben Ayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Laure","family":"Tanguy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"V\u00e9zinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Michel","family":"Siksik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maguy","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Frat\u00e9a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Movschin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Vaillant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Coriat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Hannoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,7,4]]},"reference":[{"key":"6375_CR1","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1055\/s-2003-41304","volume":"35","author":"NG Morgenthaler","year":"2003","unstructured":"Morgenthaler NG, Struck J, Chancerelle Y, Weglohner W, Agay D, Bohuon C, Suarez-Domenech V, Bergmann A, Muller B: Production of procalcitonin (PCT) in non-thyroidal tissue after LPS injection. Horm Metab Res. 2003, 35: 290-295. 10.1055\/s-2003-41304.","journal-title":"Horm Metab Res"},{"key":"6375_CR2","first-page":"67","volume":"1","author":"M Meisner","year":"1996","unstructured":"Meisner M, Tschaikowsky K, Schmidt J, Sch\u00fcttler J: Procalcitonin (PCT)-indications for a new diagnostic parameter of severe bacterial infection and sepsis in transplantation, immunosuppression and cardiac assist devices. Cardiovascular Engineering. 1996, 1: 67-76.","journal-title":"Cardiovascular Engineering"},{"key":"6375_CR3","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/s001340050683","volume":"24","author":"FM Brunkhorst","year":"1998","unstructured":"Brunkhorst FM, Heinz U, Forycki ZF: Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med. 1998, 24: 888-889. 10.1007\/s001340050683.","journal-title":"Intensive Care Med"},{"key":"6375_CR4","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/0140-6736(93)90277-N","volume":"341","author":"M Assicot","year":"1993","unstructured":"Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C: High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993, 341: 515-518. 10.1016\/0140-6736(93)90277-N.","journal-title":"Lancet"},{"key":"6375_CR5","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/00003246-200002000-00044","volume":"28","author":"ER Kuse","year":"2000","unstructured":"Kuse ER, Langefeld I, Jaeger K, K\u00fclpmann WR: Procalcitonine in fever of unknown origin after liver transplantation: a variable to differentiate acute rejection from infection. Crit Care Med. 2000, 28: 555-559. 10.1097\/00003246-200002000-00044.","journal-title":"Crit Care Med"},{"key":"6375_CR6","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1016\/S0041-1345(98)00667-8","volume":"30","author":"D Kunz","year":"1998","unstructured":"Kunz D, Pross M, K\u00f6nig W, Lippert H, Manger T: Diagnostic relevance of procalcitonin, IL-6 and cellular immune status in the early phase after liver transplantation. Transplant Proc. 1998, 30: 2398-2399. 10.1016\/S0041-1345(98)00667-8.","journal-title":"Transplant Proc"},{"key":"6375_CR7","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1097\/00007890-199304000-00024","volume":"55","author":"RJ Ploeg","year":"1993","unstructured":"Ploeg RJ, D'Alessandro A, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM, Sasaki T, Sollinger HW, Belzer FO, Kalayoglu M: Risk factors for primary dysfunction after liver transplantation \u2013 a multivariate analysis. Transplantation. 1993, 55: 807-813. 10.1097\/00007890-199304000-00024.","journal-title":"Transplantation"},{"key":"6375_CR8","unstructured":"Fazakas J, Toth S, Varga M, Svari E, Kobori L: The procalcitonin level changes after liver transplantation according to the graft flushing technique used. ILTS Milan 2006 May 3. Liver Transpl. 2006, A48-suppl"},{"key":"6375_CR9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/00042737-200605000-00012","volume":"18","author":"IS Elefsiniotis","year":"2006","unstructured":"Elefsiniotis IS, Skounakis M, Vezali E, Pantazis KD, Petrocheilou A, Pirounaki M, Papatsibas G, Kontou-Kastellanou C, Moulakakis A: Clinical significance of serum procalcitonin levels in patients with acute or chronic liver disease. Eur J Gastroenterol Hepatol. 2006, 18: 525-530. 10.1097\/00042737-200605000-00012.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"6375_CR10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1055\/s-2003-37314","volume":"41","author":"S Connert","year":"2003","unstructured":"Connert S, Stremmel W, Elsin C: Procalcitonin is a valid marker of infection in decompensated cirrhosis. Z Gastroenterol. 2003, 41: 165-170. 10.1055\/s-2003-37314.","journal-title":"Z Gastroenterol"},{"key":"6375_CR11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.lab.2005.08.005","volume":"146","author":"DP Bota","year":"2005","unstructured":"Bota DP, Van Nuffelen M, Zakariah AN, Vincent JL: Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver. J Lab Clin Med. 2005, 146: 347-351. 10.1016\/j.lab.2005.08.005.","journal-title":"J Lab Clin Med"},{"key":"6375_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1432-2277.2003.tb00334.x","volume":"16","author":"J Fazakas","year":"2003","unstructured":"Fazakas J, Gondos T, Varga M, Sarvary E, Hrovitz P, Perner F: Analysis of systemic and regional procalcitonin serum levels during liver transplantation. Transpl Int. 2003, 16: 465-470. 10.1111\/j.1432-2277.2003.tb00334.x.","journal-title":"Transpl Int"},{"key":"6375_CR13","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1053\/jlts.2003.50105","volume":"9","author":"RW Busuttil","year":"2003","unstructured":"Busuttil RW, Tanaka K: The utility of marginal donors in liver transplantation. Liver Transpl. 2003, 9: 651-663. 10.1053\/jlts.2003.50105.","journal-title":"Liver Transpl"},{"key":"6375_CR14","doi-asserted-by":"publisher","first-page":"I192","DOI":"10.1161\/hc37t1.094836","volume":"104","author":"FD Wagner","year":"2001","unstructured":"Wagner FD, Jonitz B, Potapov EV, Qedra N, Wegscheider K, Abraham K, Ivanitskaia EA, Loebe M, Hetzer R: Procalcitonin, a donor-specific predictor of early graft failure-related mortality after heart transplantation. Circulation. 2001, 104 (): I192-I196. 10.1161\/hc37t1.094836.","journal-title":"Circulation"},{"key":"6375_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0167-5273(03)00083-4","volume":"92","author":"EV Potapov","year":"2003","unstructured":"Potapov EV, Wagner FD, Loebe M, Ivanitskaia EA, M\u00fcller C, Sodian R, Jonitz B, Hetzer R: Elevated donor cardiac troponin T and procalcitonin indicate two independent mechanisms of early graft failure after heart transplantation. Int J Cardiol. 2003, 92: 163-167. 10.1016\/S0167-5273(03)00083-4.","journal-title":"Int J Cardiol"},{"key":"6375_CR16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/BF01740811","volume":"25","author":"W Karza\u00ef","year":"1997","unstructured":"Karza\u00ef W, Oberhoffer M, Meier-Hellmann A, Reinhart K: Procalcitonin: a new indicator of the systemic response to sever infections. Infection. 1997, 25: 329-334. 10.1007\/BF01740811.","journal-title":"Infection"},{"key":"6375_CR17","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1186\/cc3910","volume":"10","author":"M Meisner","year":"2006","unstructured":"Meisner M, Adina H, Schmidt J: Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients. Crit Care. 2006, 10: R1-10.1186\/cc3910.","journal-title":"Crit Care"},{"key":"6375_CR18","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1086\/513633","volume":"24","author":"D Gendrel","year":"1997","unstructured":"Gendrel D, Raymond J, Assicot M, Moulin F, Iniquez JL, Lebon P, Bohuon C: Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin Infect Dis. 1997, 24: 1240-1242. 10.1086\/513633.","journal-title":"Clin Infect Dis"},{"key":"6375_CR19","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/S0140-6736(04)15591-8","volume":"363","author":"M Christ-Crain","year":"2004","unstructured":"Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, M\u00fcller B: Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trail. Lancet. 2004, 363: 600-607. 10.1016\/S0140-6736(04)15591-8.","journal-title":"Lancet"},{"key":"6375_CR20","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1097\/00003246-199806000-00015","volume":"26","author":"ES Nylen","year":"1998","unstructured":"Nylen ES, Whang KT, Snider RH, Steinwald PM, White JC, Becker KL: Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med. 1998, 26: 1001-1006. 10.1097\/00003246-199806000-00015.","journal-title":"Crit Care Med"},{"key":"6375_CR21","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1210\/jc.79.6.1605","volume":"79","author":"P Dandona","year":"1994","unstructured":"Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, Bohuon C: Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab. 1994, 79: 1605-1608. 10.1210\/jc.79.6.1605.","journal-title":"J Clin Endocrinol Metab"},{"key":"6375_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0167-5273(99)00118-7","volume":"72","author":"FM Brunkhorst","year":"1999","unstructured":"Brunkhorst FM, Clark AL, Forycki ZF, Anker SD, Feyrer R: Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: the potential importance of bacterial translocation. Int J Cardiol. 1999, 72: 3-10. 10.1016\/S0167-5273(99)00118-7.","journal-title":"Int J Cardiol"},{"key":"6375_CR23","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s001340100949","volume":"27","author":"R Sabat","year":"2001","unstructured":"Sabat R, H\u00f6flich C, D\u00f6cke WD, Oppert M, Kern F, Windrich B, Rosenberger C, Kaden J, Volk HD, Reinke P: Massive elevation of procalcitonin plasma levels in the absence of infection in kidney transplant patients treated with pan-T-cell antibodies. Intensive Care Med. 2001, 27: 987-991. 10.1007\/s001340100949.","journal-title":"Intensive Care Med"},{"key":"6375_CR24","doi-asserted-by":"publisher","first-page":"R131","DOI":"10.1186\/cc6202","volume":"11","author":"R Zazula","year":"2007","unstructured":"Zazula R, Prucha M, Tyll T, Kieslichova E: Induction of procalcitonin in liver transplants treated with anti-thymocyte globulin. Crit Care. 2007, 11: R131-10.1186\/cc6202.","journal-title":"Crit Care"},{"key":"6375_CR25","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1007\/s00134-002-1392-5","volume":"28","author":"M Meisner","year":"2002","unstructured":"Meisner M, Raushmayer C, Schmidt J, Feyrer R, Cesnjevar R, Bredle D, Tscha\u00efkowsky K: Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complication. Inensive Care Med. 2002, 28: 1094-1102. 10.1007\/s00134-002-1392-5.","journal-title":"Inensive Care Med"},{"key":"6375_CR26","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/00003246-200102000-00019","volume":"29","author":"JB Lecharny","year":"2001","unstructured":"Lecharny JB, Khater D, Bronchard R, Philip I, Durand G, Desmonts JM, Dehoux M: Hyperprocalcitoninemia in patients with perioperative myocardial infarction after cardiac surgery. Crit Care Med. 2001, 29: 323-325. 10.1097\/00003246-200102000-00019.","journal-title":"Crit Care Med"},{"key":"6375_CR27","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1097\/00003246-200009000-00008","volume":"28","author":"A Aouifi","year":"2000","unstructured":"Aouifi A, Piriou V, Bastien O, Blanc P, Bouvier H, Evans R, Celard M, Vandenesch F, Rousson R, Lehot JJ: Usefulness of procalciton for diagnosis of infection in cardiac surgical patients. Crit Care Med. 2000, 28: 3171-3176. 10.1097\/00003246-200009000-00008.","journal-title":"Crit Care Med"},{"key":"6375_CR28","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1097\/00003246-199708000-00024","volume":"25","author":"ES Nylen","year":"1997","unstructured":"Nylen ES, Al Arifi A, Becker KL, Snider RH, Alzeer A: Effect of classic heatstroke on serum procalcitonin. Crit Care Med. 1997, 25: 1362-1365. 10.1097\/00003246-199708000-00024.","journal-title":"Crit Care Med"},{"key":"6375_CR29","first-page":"205","volume":"114","author":"M Remskar","year":"2002","unstructured":"Remskar M, Horvat M, Hojker S, Noc M: Procalcitonin in patients with acute myocardial infarction. Wien Klin Wochenschr. 2002, 114: 205-210.","journal-title":"Wien Klin Wochenschr"},{"key":"6375_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0300-9572(03)00164-3","volume":"59","author":"M Fries","year":"2003","unstructured":"Fries M, Kunz D, Gressner AM, Rossaint R, Kuhlen R: Procalcitonin serum levels after out-of-hospital cardiac arrest. Resuscitation. 2003, 59: 105-109. 10.1016\/S0300-9572(03)00164-3.","journal-title":"Resuscitation"},{"key":"6375_CR31","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1097\/01.TP.0000064542.63798.6B","volume":"75","author":"DJ Wilson","year":"2003","unstructured":"Wilson DJ, Fischer A, Das K, Goerlitz F, Holland BK, De la Torre A, Merchant A, Seguel J, Samanta AK, Koneru B: Donors with cardiac arrest: improved organ recovery but no preconditioning benefit in liver allograft. Transplantation. 2003, 75: 1683-1687. 10.1097\/01.TP.0000064542.63798.6B.","journal-title":"Transplantation"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc6942.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/cc6942\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc6942.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T12:17:07Z","timestamp":1728303427000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/cc6942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,4]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2008,8]]}},"alternative-id":["6375"],"URL":"https:\/\/doi.org\/10.1186\/cc6942","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,4]]},"assertion":[{"value":"11 March 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R85"}}